Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-15-004201
Filing Date
2015-05-14
Accepted
2015-05-14 16:59:04
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imdz331201510-q.htm 10-Q 764776
2 EXHIBIT 31.1 ex311imdz2015q1.htm EX-31.1 7597
3 EXHIBIT 31.2 ex312imdz2015q1.htm EX-31.2 7968
4 EXHIBIT 32.1 ex321imdz2015q1.htm EX-32.1 4820
5 EXHIBIT 32.2 ex322imdz2015q1.htm EX-32.2 5056
  Complete submission text file 0001628280-15-004201.txt   4148939

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imdz-20150331.xml EX-101.INS 462926
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20150331.xsd EX-101.SCH 29746
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20150331_cal.xml EX-101.CAL 43232
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20150331_def.xml EX-101.DEF 122291
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20150331_lab.xml EX-101.LAB 405668
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20150331_pre.xml EX-101.PRE 228281
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

EIN.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 15863778
SIC: 2834 Pharmaceutical Preparations